RPLP0P11

Across TCGA pan-cancer cohorts, RPLP0P11 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RPLP0P11’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPLP0P11 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPLP0P11 is over-expressed in tumor.

LUSC, HNSC, and LIHC are the cancer types where RPLP0P11 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPLP0P11 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.044	.005	4	view →
HNSC	Male	All	+0.037	.016	3	view →
LIHC	All	All	+0.036	.018	2	view →
PRAD	All	All	+0.021	.048	2	view →
COAD	Female	All	+0.153	.037	1	view →
THCA	Male	All	+0.018	.036	1	view →
KIRC	All	All	+0.013	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

RPLP0P11–LUSC

Open the LUSC breakdown →